{
    "nctId": "NCT03377816",
    "briefTitle": "The Role of Emotional Processing in Improving the Quality of Life of Breast Cancer Patients",
    "officialTitle": "The Role of Emotional Processing in Improving the Quality of Life of Breast Cancer Patients: a Mechanistic Study of Art Therapy in Reducing Depression, Fatigue and Pain.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female, Depressive Symptoms, Fatigue, Pain, Emotions, Inflammation",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 318,
    "primaryOutcomeMeasure": "Depression Depression",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* adult (\\>18) females with initial or recurrent BC\n* intervention can begin 3 months after finishing chemotherapy and radiotherapy (RT) and one month after surgery, up until 18 months after treatment completion.\n* can complete assessments in Arabic or Hebrew\n* provides informed consent.\n\nExclusion Criteria:\n\n* male\n* lifetime history of bipolar disorder, schizophrenia, schizoaffective disorder or with a pre- cancer diagnosis of fibromyalgia or chronic fatigue syndrome\n* active suicidal plan (will ensure immediate intervention);\n* dementia/other disorder that would preclude informed consent or comprehension of assessments\n* Individuals taking anticholinergic medications, and post myocardial infarction (6 months before recruitment) or with a pacemaker, which would render the metric of HRV invalid.\n* Flare-up in systemic autoimmune disease (such as arthritis, lupus or multiple sclerosis), thyroid dysfunction that requires increases in medication",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}